enercare inc (ECI:Toronto)
William M. Wells
Additional Director, Chairman of Corporate Responsibility & Risk Management Committee, Member of Audit Committee and Member of Investment Committee, EnerCare Inc.
|Age||Total Calculated Compensation||This person is connected to 27 board members in 4 different organizations across 9 different industries.|
See Board Relationships
Mr. William M. Wells, also known as Bill, served as the Chief Executive Officer and President of Valeant International (Barbados) SRL (also known as, Valeant International Bermuda). Mr. Wells served as the Chief Executive Officer and President of Valeant Pharmaceuticals International, Inc. from May 1, 2008 to 2010. He served as the Chief Executive Officer of Biovail Corporation ("Biovail") from May 2008 to September 2010. As Chief Executive Officer of Biovail, he led ...
4000 Victoria Park AvenuePhone: 416-649-1860
Toronto, Ontario M2H 3P4
Board Members Memberships*
Former President, Member of Risk & Compliance Committee, Chief Executive Officer of Biovail Laboratories International SRL and President of Biovail Laboratories International SRL
Independent Director and Member of Nominating & Corporate Governance Committee
Additional Director, Chairman of Corporate Responsibility & Risk Management Committee, Member of Audit Committee and Member of Investment Committee
Director, Member of Investment Committee and Member of Audit Committee
Former Director and Chairman of Audit Committee
Master's Degree 1983
University of South Carolina
The University Of Western Ontario
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|Dilip Shantilal Shanghvi||Managing Director, Executive Director and Member of Shareholders/Investors Grievance Committee|
Sun Pharmaceutical Industries Limited
|Heather Bresch||Chief Executive Officer, Director and Member of Science & Technology Committee|
|Flemming Ornskov M.D., MBA, MPH||Managing Director, Chief Executive Officer and Director|
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|--||Compensation as of Fiscal Year --.|